Conversely, patients with IBS-C (constipation-predominant) may experience worsening symptoms when using these medications
Both tirzepatide and excess thyroid hormone can cause diarrhea , sulfur burps , nausea, and changes in bowel habits
Clinically, that 5% mark is meaningful: its commonly used as a benchmark for whether a medication is providing benefit, not as a final outcome
Versus other triple/multi-agonists in development : survodutide (GLP-1/GCGR Boehringer Ingelheim), mazdutide (GLP-1/GCGR Eli Lilly), orforglipron (oral non-peptide GLP-1 Eli Lilly), HRS9531 (GLP-1/GIP Hengrui): each represents a distinct signaling architecture
Cinnoxicam and carnitines appear to have complementary mechanistic pathways, which facilitate the suppression of excess prostaglandin production, which could lead to improvement in sperm quality